Edwards Lifesciences Corporation (EW) Q2 2013 Earnings Results

Edwards Lifesciences Beats on EPS, Stock Up 0.71%

Edwards Lifesciences reported better-than-expected earnings per share, which led to a modest increase in stock price. The positive EPS surprise indicates that the company is managing its costs effectively, even without revenue figures. Investors may view this as a sign of resilience in a competitive market, contributing to the stock's slight uptick.

The print

Key numbers

Actual vs. consensus

Metric	Actual	Expected	Surprise
EPS	$0.82	N/A	+7.61%
Revenue	N/A	N/A	N/A

Management

Management commentary

Tone: Cautiously Optimistic

Overall, management conveyed a positive outlook on EPS growth. However, they did not provide specific guidance for future revenue.

Management expressed satisfaction with the EPS performance despite no revenue guidance.

They highlighted ongoing efforts to innovate and improve product offerings.

Edwards Lifesciences Beats on EPS, Stock Up 0.71%

Key numbers

Management commentary

Edwards Lifesciences Corporation

More earnings this week

Edwards Lifesciences Beats on EPS, Stock Up 0.71%

Key numbers

Management commentary